This investment reinforces our commitment to the probiotics industry. We see strong growth worldwide, and increasing our capacity enables our partners to continue growing and capturing the opportunities from very favorable market trends.
NEW CENTURY, Kan. (PRWEB) November 01, 2016
Today DuPont Nutrition & Health announced a significant investment to expand probiotics production capacity in the United States. The investment is the second phase of a broader probiotics expansion project due to the rapidly growing global demand for probiotics. Phase One, supporting current growth, is ongoing in Madison, Wis., and Rochester, N.Y., and will be partially complete by the end of 2016. The second phase is scheduled to span two-years, represents an investment of approximately $100 million, and increases the company’s probiotics production capacity by an additional 70 percent. Production will be optimized with the installation of new, high-volume fermenters and other processing equipment.
“This investment reinforces our commitment to the probiotics industry. We see strong growth worldwide, and increasing our capacity enables our partners to continue growing and capturing the opportunities from very favorable market trends,” said Matthias Heinzel, president, DuPont Nutrition & Health. “As we phase in more capacity, we will continue to maintain the high potency, stability and efficacy in our products that have made DuPont the global probiotics leader. Quality is extremely important in probiotic production, and our reputation for manufacturing quality has always been a differentiator with DuPont probiotics.”
Probiotics have seen rapid adoption. In the United States, consumer awareness is at an all-time high (75 percent), according to the Natural Marketing Institute. Further evidence of worldwide probiotic acceptance is reflected in Euromonitor data that shows an increase in the compound annual growth rate for 2015 to 2020 in every global region – from 4.5 percent in Asia Pacific to 26 percent in South America. Health-conscious consumers are addressing personal health concerns by including probiotics in their daily health and wellness routines. “Consumers want to proactively take care of their health, and they’re increasingly turning to probiotics to fill that need,” said John Rea, global business unit leader for Probiotics, Cultures, Food Protection and HMOs. “We have found through proprietary research that consumers feel probiotics offer a great way to improve their overall health and wellness. And they see probiotics playing the role of a ‘balancer’ in the midst of a stress-filled, fast-paced lifestyle(1).”
For more than 30 years, DuPont Nutrition & Health has been a global leader in the science, research and production of probiotics. Today DuPont continues that tradition with microbiome work, researching novel uses of probiotics for health and wellness. DuPont™ Danisco® HOWARU® premium probiotics and FloraFit® custom probiotics, which are used in food, beverage, dietary supplement and animal nutrition products, are produced at the Rochester location. The broad portfolio of DuPont probiotic strains is backed by comprehensive clinical studies and documentation, showing efficacy in the support of immune and digestive health. DuPont probiotics offer customers:
- The widest range of stable, clinically documented probiotics
- Application in novel delivery formats
- Specialized sales and technical support
- Expert legal and regulatory support
- Finished product format options
DuPont Nutrition & Health combines in-depth knowledge of food and nutrition with current research and expert science to deliver unmatched value to the food, beverage and dietary supplement industries. We are innovative solvers, drawing on deep consumer insights and a broad product portfolio to help our customers turn challenges into high-value business opportunities. More information is available at http://www.food.dupont.com.
DuPont (NYSE: DD) has been bringing world-class science and engineering to the global marketplace in the form of innovative products, materials, and services since 1802. The company believes that by collaborating with customers, governments, NGOs, and thought leaders we can help find solutions to such global challenges as providing enough healthy food for people everywhere, decreasing dependence on fossil fuels, and protecting life and the environment. For additional information about DuPont and its commitment to inclusive innovation, please visit http://www.dupont.com.
Forward-Looking Statements: This communication contains “forward-looking statements” within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In this context, forward-looking statements often address expected future business and financial performance and financial condition, and often contain words such as “expect,” “anticipate,” “intend,” “plan,” “believe,” “seek,” “see,” “will,” “would,” “target,” similar expressions, and variations or negatives of these words. Forward-looking statements by their nature address matters that are, to different degrees, uncertain, such as statements about the consummation of the proposed transaction and the anticipated benefits thereof. Forward-looking statements are not guarantees of future performance and are based on certain assumptions and expectations of future events which may not be realized. Forward-looking statements also involve risks and uncertainties, many of which are beyond the company’s control. Some of the important factors that could cause the company’s actual results to differ materially from those projected in any such forward-looking statements are: fluctuations in energy and raw material prices; failure to develop and market new products and optimally manage product life cycles; ability to respond to market acceptance, rules, regulations and policies affecting products based on biotechnology and, in general, for products for the agriculture industry; outcome of significant litigation and environmental matters, including realization of associated indemnification assets, if any; failure to appropriately manage process safety and product stewardship issues; changes in laws and regulations or political conditions; global economic and capital markets conditions, such as inflation, interest and currency exchange rates; business or supply disruptions; security threats, such as acts of sabotage, terrorism or war, natural disasters and weather events and patterns which could affect demand as well as availability of products for the agriculture industry; ability to protect and enforce the company’s intellectual property rights; successful integration of acquired businesses and separation of underperforming or non-strategic assets or businesses; and risks related to the agreement entered on December 11, 2015, with The Dow Chemical Company pursuant to which the companies have agreed to effect an all-stock merger of equals, including the completion of the proposed transaction on anticipated terms and timing, the ability to fully and timely realize the expected benefits of the proposed transaction and risks related to the intended business separations contemplated to occur after the completion of the proposed transaction. The company undertakes no duty to publicly revise or update any forward-looking statements as a result of future developments, or new information or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws.
# # #
The DuPont Oval logo, DuPont™, Danisco®and all products, unless otherwise noted, denoted with ™, ℠ or ® are trademarks or registered trademarks of E.I. du Pont de Nemours and Company or its affiliates.
(1) DuPont proprietary research conducted by 20/20 Research, Inc., May 2015.